How EMTT® Is Revolutionizing Regenerative Medicine
Dr. Gerdesmeyer, a global leader in regenerative medicine and orthopedics, serves as Head of the Department of Orthopedic Surgery and Traumatology at MedBaltic – Ortho Trauma Center in Kiel, Germany. He is also Chairman of the ISMST Research Committee and Co-Author of Shockwave: Multidisciplinary Medical Applications from the Level 10 Series. His extensive research and clinical experience span joint arthroplasty, joint-preserving techniques, spine surgery, and pain management, making him one of the foremost voices advancing evidence-based applications of EMTT and Shockwave worldwide.
✔ Why EMTT is gaining global attention and acclaim
✔ How it differs from traditional magnetic field devices (PEMF)
✔ What recent evidence reveals about its revolutionary clinical power
Dr. Gerdesmeyer clearly explains the scientific foundation of Extracorporeal Magnetotransduction Therapy, delving into how it works and why it represents a leap far beyond conventional magnetic field devices.
Extracorporeal Magnetotransduction Therapy is an electromagnetically induced energy transfer that releases high-frequency magnetic fields converted into therapeutic electric fields within tissue.
With the fundamentals established, Dr. Gerdesmeyer takes a scientific deep dive into the physics, explaining why not all "magnetic" devices meet the strict scientific definition or therapeutic potential of EMTT.
✔ >60 kilotesla per second magnetic transduction power
✔ >100 kHz frequency to trigger electric field induction
✔ Rapid oscillation = real therapeutic energy transfer
The key to effective Extracorporeal Magnetotransduction Therapy lies in speed and intensity; the faster and stronger the field change, the greater the biological response.
Once this foundation of energy and biology is fully understood, the next step is examining how EMTT translates these physical principles into measurable healing effects.
Dr. Gerdesmeyer's research reveals that EMTT exerts multiple biological effects at cellular and genetic levels.
✔ Activation of calcium influx in osteoblasts within 10 minutes
✔ Upregulation of collagen I and III, VEGF, and BMP expression
✔ Improved cell mobility and cytoskeletal organization
✔ Enhanced electroporation and piezoelectric activity to boost metabolism
The above processes enhance bone regeneration, soft-tissue remodeling, and inflammation resolution, creating an ideal healing environment.
Next, Dr. Gerdesmeyer expands on how these clinically-proven mechanisms perform in real-world clinical scenarios.
In the webinar, Dr. Gerdesmeyer shared key clinical data demonstrating EMTT's efficacy across multiple conditions:
✔ Failed Back Surgery Syndrome (FBSS): EMTT patients experienced greater pain reduction and functional recovery versus placebo at 6 and 12 weeks.
✔ Osteitis Pubis in Athletes: Four EMTT sessions led to faster pain relief and earlier return to sport.
✔ Degenerative Joint Disease and Tendinopathies: Placebo-controlled study (126 patients) showed significant improvements in pain and SF-12 scores compared with controls.
Consistent effectiveness was observed across musculoskeletal, sports, and post-surgical care.
As positive clinical evidence accumulated, Dr. Gerdesmeyer additionally found that healing advanced even further when combining EMTT with another evidence-based medical technology, Extracorporeal Shockwave Therapy (ESWT).
Combined Clinical Protocol:
Synergy in Action: EMTT ignites energy metabolism, while Shockwave delivers mechanical signaling resulting in optimized recovery and tissue repair.
This combined treatment approach has opened new therapeutic possibilities and expanded EMTT's role far beyond musculoskeletal medicine.
Dr. Gerdesmeyer's findings confirm EMTT's versatility across multiple medical domains:
✔ Acute and Chronic Inflammation – Resolving pain and restoring function
✔ Bone Surgery and Nonunions – Enhancing consolidation and healing rates
✔ Sports Injuries and Overuse Syndromes – Promoting faster tissue recovery
✔ Neurological Applications – Potential roles in ischemic and depressive conditions
✔ Postoperative Integration – Applied immediately after surgery for optimized healing
"EMTT is one of the best soft-tissue engineers in modern medicine."
– Dr. Ludger Gerdesmeyer.
Practical Insights for Providers:
✔ Pulse count: ~10,000 per session (5,000 minimum for effect)
✔ Frequency: Daily for acute, 2× weekly for chronic cases
✔ Contraindication: Avoid use with pacemakers or electrical implants
✔ Safety: Suitable across all ages, including adolescent athletes
For clinicians looking to deepen their understanding, the full webinar offers a comprehensive overview of EMTT science, clinical outcomes, and integration strategies.
You'll Learn:
✔ How to distinguish EMTT from lower-powered magnetic field devices (PEMF)
✔ The evidence supporting EMTT's regenerative mechanisms
✔ Clinical examples of EMTT + Shockwave synergy
✔ Real-world protocols from Dr. Gerdesmeyer's orthopedic practice
✔ EMTT delivers high-frequency electromagnetic energy that converts into therapeutic electric fields, stimulating metabolism and tissue repair.
✔ Clinical studies show significant benefits for bone healing, tendinopathies, and inflammation when EMTT is used alone or combined with Shockwave.
✔ As part of a multimodal regenerative approach, EMTT enhances recovery, improves outcomes, and broadens non-invasive treatment options across specialties.
Partnering with CuraMedix ensures access to STORZ Medical's gold-standard Shockwave and EMTT technologies, comprehensive training, and ongoing support to help you deliver next-level outcomes in patient care.
Contact us today to explore how EMTT can advance your clinical results and practice growth.